CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 152 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $173,000 | -86.0% | 345,067 | -34.8% | 0.00% | -88.5% |
Q1 2018 | $1,232,000 | -5.2% | 528,874 | +19.3% | 0.03% | -7.1% |
Q4 2017 | $1,299,000 | +964.8% | 443,455 | +937.7% | 0.03% | +1300.0% |
Q3 2017 | $122,000 | -91.7% | 42,735 | -88.2% | 0.00% | -95.6% |
Q3 2016 | $1,466,000 | -83.1% | 362,828 | -33.9% | 0.04% | -78.0% |
Q4 2015 | $8,695,000 | +697.0% | 548,708 | +430.1% | 0.20% | +502.9% |
Q3 2015 | $1,091,000 | -24.0% | 103,508 | +27.4% | 0.03% | -19.0% |
Q1 2014 | $1,435,000 | +48.2% | 81,223 | +103.1% | 0.04% | +75.0% |
Q4 2013 | $968,000 | -81.9% | 39,996 | -88.3% | 0.02% | -83.4% |
Q2 2013 | $5,350,000 | – | 342,739 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $24,302,000 | 100.00% |
TSP Capital Management Group, LLC | 886,398 | $3,138,000 | 1.60% |
Marcus Capital, LLC | 109,950 | $389,000 | 0.42% |
RTW INVESTMENTS, LP | 239,662 | $848,000 | 0.32% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 6,195,855 | $21,933,000 | 0.31% |
Benchmark Capital Advisors | 66,800 | $236,000 | 0.20% |
Bellevue Group AG | 160,000 | $566,000 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 632,944 | $2,241,000 | 0.09% |
PDT Partners, LLC | 369,300 | $1,307,000 | 0.09% |
Vident Investment Advisory, LLC | 196,715 | $696,000 | 0.08% |